Jagsonpal Pharmaceuticals Ltd. - Research Center
507789 JAGSNPHARM Group (B) BSE data
Add to watchlist
| Results | |
| Statement |
Balance sheet
|
| More |
Balance sheet
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sources of funds | |||||
| Owner's fund | |||||
| Equity share capital | 13.10 | 13.10 | 13.10 | 13.10 | 13.10 |
| Share application money | - | - | - | - | - |
| Preference share capital | - | - | - | - | - |
| Reserves & surplus | 145.79 | 109.92 | 100.99 | 90.10 | 83.53 |
| Loan funds | |||||
| Secured loans | - | - | 6.79 | 4.66 | 3.79 |
| Unsecured loans | - | - | - | - | - |
| Total | 158.89 | 123.02 | 120.88 | 107.86 | 100.42 |
| Uses of funds | |||||
| Fixed assets | |||||
| Gross block | 32.87 | 60.28 | 60.12 | 55.83 | 55.00 |
| Less : revaluation reserve | - | 7.84 | 7.84 | 7.84 | 7.84 |
| Less : accumulated depreciation | 8.59 | 35.53 | 34.40 | 33.74 | 33.36 |
| Net block | 24.28 | 16.91 | 17.88 | 14.25 | 13.80 |
| Capital work-in-progress | - | - | - | 4.25 | 3.95 |
| Investments | 1.12 | 42.72 | 15.31 | 11.39 | - |
| Net current assets | |||||
| Current assets, loans & advances | 169.55 | 100.99 | 123.17 | 109.23 | 110.19 |
| Less : current liabilities & provisions | 36.06 | 37.60 | 35.49 | 31.26 | 27.53 |
| Total net current assets | 133.49 | 63.39 | 87.69 | 77.97 | 82.66 |
| Miscellaneous expenses not written | - | - | - | - | - |
| Total | 158.89 | 123.02 | 120.88 | 107.86 | 100.42 |
| Notes: | |||||
| Book value of unquoted investments | 1.02 | 20.58 | 12.06 | 11.39 | - |
| Market value of quoted investments | - | - | - | - | - |
| Contingent liabilities | 6.09 | 5.87 | 5.99 | 6.06 | 0.69 |
| Number of equity sharesoutstanding (Lacs) | 261.98 | 261.98 | 261.98 | 261.98 | 261.98 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis